H19 and breast carcinoma: The study also found that high expression levels of LincRNA H19, miR-675, MRP3, HOXA1, and MMP16 were more common in patients with early-stage breast cancer (TNM stages I or II) and those diagnosed with invasive ductal carcinoma (IDC), suggesting their utility as early diagnostic markers to facilitate the early detection and treatment of IDC.